Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 46.55 TWD -0.43% Market Closed
Market Cap: NT$4.2B

Operating Margin

30%
Current
Improving
by 4.5%
vs 3-y average of 25.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
30%
=
Operating Income
NT$238m
/
Revenue
NT$792.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
30%
=
Operating Income
NT$238m
/
Revenue
NT$792.6m

Peer Comparison

Country Company Market Cap Operating
Margin
TW
Maxigen Biotech Inc
TWSE:1783
4.2B TWD
Loading...
FR
L'Oreal SA
PAR:OR
204.9B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.9B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
34.2B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
42.4B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.4B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
920.5B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 94% of companies in Taiwan
Percentile
94rd
Based on 1 045 companies
94rd percentile
30%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

Maxigen Biotech Inc
Glance View

Market Cap
4.2B TWD
Industry
Consumer products

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Intrinsic Value
36.62 TWD
Overvaluation 21%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
30%
=
Operating Income
NT$238m
/
Revenue
NT$792.6m
What is Maxigen Biotech Inc's current Operating Margin?

The current Operating Margin for Maxigen Biotech Inc is 30%, which is above its 3-year median of 25.5%.

How has Operating Margin changed over time?

Over the last 3 years, Maxigen Biotech Inc’s Operating Margin has increased from 16.3% to 30%. During this period, it reached a low of 16.3% on Aug 30, 2022 and a high of 30.7% on Jun 30, 2025.

Back to Top